ntp-atenolol/chlorthalidone tablet
teva canada limited - atenolol; chlorthalidone - tablet - 50mg; 25mg - atenolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents
ntp-atenolol/chlorthalidone tablet
teva canada limited - chlorthalidone; atenolol - tablet - 25mg; 100mg - chlorthalidone 25mg; atenolol 100mg - beta-adrenergic blocking agents
teva-atenolol/chlorthalidone tablet
teva canada limited - atenolol; chlorthalidone - tablet - 50mg; 25mg - atenolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents
teva-atenolol/chlorthalidone tablet
teva canada limited - atenolol; chlorthalidone - tablet - 100mg; 25mg - atenolol 100mg; chlorthalidone 25mg - beta-adrenergic blocking agents
teva-atenolol/chlorthalidone comprimé
teva canada limited - aténolol; chlorthalidone - comprimé - 50mg; 25mg - aténolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents
teva-atenolol/chlorthalidone comprimé
teva canada limited - aténolol; chlorthalidone - comprimé - 100mg; 25mg - aténolol 100mg; chlorthalidone 25mg - beta-adrenergic blocking agents
ntp-atenolol/chlorthalidone comprimé
teva canada limited - aténolol; chlorthalidone - comprimé - 50mg; 25mg - aténolol 50mg; chlorthalidone 25mg - beta-adrenergic blocking agents
ntp-atenolol/chlorthalidone comprimé
teva canada limited - chlorthalidone; aténolol - comprimé - 25mg; 100mg - chlorthalidone 25mg; aténolol 100mg - beta-adrenergic blocking agents
atenolol and chlorthalidone- atenolol and chlorthalidone tablet
mylan pharmaceuticals inc. - atenolol (unii: 50vv3vw0ti) (atenolol - unii:50vv3vw0ti), chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - atenolol 50 mg - atenolol and chlorthalidone tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmac
atenolol and chlorthalidone tablet
mutual pharmaceutical company, inc. - atenolol (unii: 50vv3vw0ti) (atenolol - unii:50vv3vw0ti), chlorthalidone (unii: q0mqd1073q) (chlorthalidone - unii:q0mqd1073q) - atenolol 50 mg - atenolol and chlorthalidone tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmac